FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Voigtlander Christian B.
  2. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE [ICUI] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Operating Officer
(Last)
(First)
(Middle)
951 CALLE AMANECER		 3. Date of Earliest Transaction (Month/Day/Year)
03/07/2024
(Street)

SAN CLEMENTE, CA 92673		 4. If Amendment, Date Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4) 		7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock (1) 03/07/2024   M   2,145 A $ 0 2,145 D  
Common Stock 03/07/2024   F   1,175 D $ 105.39 970 D  
Common Stock (2) 03/07/2024   M   12,872 A $ 0 13,842 D  
Common Stock 03/07/2024   F   7,059 D $ 105.39 6,783 D  
Common Stock (1) 03/08/2024   M   2,210 A $ 0 8,993 D  
Common Stock 03/08/2024   F   1,212 D $ 104.52 7,781 D  
Common Stock (2) 03/08/2024   M   7,289 A $ 0 15,070 D  
Common Stock 03/08/2024   F   3,998 D $ 104.52 11,072 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5) 		6. Date Exercisable and Expiration Date
(Month/Day/Year) 		7. Title and Amount of Underlying Securities
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4) 		10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4) 		11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock (1) $ 0 (3) 03/08/2024   M     2,210 03/08/2023(4) 03/08/2024(5) Common Stock 2,210 $ 0 0 D  
Common Stock (1) $ 0 (3) 03/07/2024   M     2,145 03/07/2023(4) 03/07/2025(5) Common Stock 2,145 $ 0 2,146 D  
Performance Shares (2) $ 0 (6) 03/07/2024   M     12,872   (7) 03/07/2024 Common Stock 12,872 $ 0 0 D  
Performance Shares (2) $ 0 (6) 03/08/2024   M     7,289   (8) 03/08/2024 Common Stock 7,289 $ 0 0 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Voigtlander Christian B.
951 CALLE AMANECER
SAN CLEMENTE, CA 92673		       Chief Operating Officer  

Signatures

 By: Paula Darbyshire, Attorney-in-fact For: Christian Voigtlander   03/11/2024
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) These securities are Restricted Stock Units.
(2) These Securities are Performance-based Restricted Stock Units (PRSU).
(3) There is neither a purchase price nor an exercise price for the Restricted Stock Units.
(4) One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
(5) These are restricted stock units that fully vest 3 years from the grant date.
(6) There is neither a purchase price nor an exercise price for the PRSUs.
(7) These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant.
(8) These PRSUs were granted on March 8, 2021 and had a 3-Year cliff-vest subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 110% of the original grant.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.